Explain this page
Arphra AIPlain-English read on Replimune Group, Inc.’s valuationAI Issuer Brief
Arphra AILoading cached brief…
Fair value
Football field →Weighted blend
—
— vs spot
Recommendation
n/a
0 of 0 methods
Method spread
0bull0bear
±5% threshold
Analyst PT consensus: $14.00 (+56.16%)
Price change · trailing returns
Live| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| -5.33% | +1.88% | +120.27% | +11.09% | -16.45% | -7.77% | -11.94% | -60.26% | -72.60% | -40.86% | -40.86% |
Insider · 30d
History →Bought
$0
0 txns
Sold
$110.88K
1 txn
Net flow
−$110.88K
Aftermarket
LiveLast trade
$8.96
130 sh
Bid
$6.66
2 sh
Ask
$11.22
2 sh
Spread
$4.560
Recent quarters
All financials →| Period | Revenue | Net income | EPS |
|---|
Sector & industry today
LiveSectors
- Communication Services+0.60%
- Financial Services+0.36%
- Consumer Cyclical+0.20%
- Technology+0.16%
- Energy+0.05%
- Healthcare-0.28%
- Consumer Defensive-0.37%
- Industrials-0.63%
- Utilities-0.83%
- Basic Materials-0.99%
- Real Estate-1.51%
Top industries (issuer's industry highlighted)
- Biotechnology-2.38%
- Solar-8.68%
- REIT - Healthcare Facilities-3.60%
- Copper-3.14%
- Financial - Mortgages-3.03%
- Construction Materials-2.63%
- Communication Equipment-2.56%
- Auto - Dealerships+2.54%
- Medical - Healthcare Information Services-2.46%
- Rental & Leasing Services+2.39%
- Medical - Healthcare Plans+2.36%
- Trucking+2.34%
Analyst view
Consensus target
—
No price-target data returned for this ticker.
Recent actions
0 ↑0 ↓0 hold
- No recent grade actions.
News
DB · news_items- Replimune: Perhaps The FDA Shakeup Will Get A Mulligan For RP1seekingalpha.com·May 13, 2026
- INVESTOR ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Replimune Group, Inc. – REPLglobenewswire.com·May 12, 2026
- INVESTOR ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Replimune Group, Inc. – REPLglobenewswire.com·May 12, 2026
- INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Replimune Group, Inc. - REPLprnewswire.com·May 07, 2026
- INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Replimune Group, Inc. - REPLprnewswire.com·Apr 30, 2026
Peers
No peer list available for REPL.
Total assets
—
Total debt
—
Cash & equiv
—
Operating CF
—
Free cash flow
—
Buybacks
—
Recent insiders
All →| Insider | Action | Shares | Value | Date |
|---|---|---|---|---|
Sarchi Christopher officer: Chief Commercial Officer | Sell | 12,000 | $110.88K | Jun 01, 2026 |
Income statement · annual
5y| Period | Revenue | Op income | Net income | EPS | Net margin |
|---|